REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 336.50
Ask: 338.50
Change: 19.00 (6.01%)
Spread: 2.00 (0.594%)
Open: 319.50
High: 341.00
Low: 319.50
Prev. Close: 316.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Recession fear hits stocks; Oxford Biomedica rises

Fri, 01st Jul 2022 08:56

(Alliance News) - Stocks in London opened lower on Friday as investors continued to fret over prospects of a recession as central banks raise interest rates.

Comments from central bankers, including Federal Reserve Chair Jerome Powell, suggest they are willing to endure the pain of a contraction as long as they can rein in rising prices.

More positively, Oxford Biomedica shares rose on a new Covid-19 vaccine deal with AstraZeneca.

The FTSE 100 index was down 40.52 points, or 0.6%, at 7,128.76. The FTSE 250 index was down 105.80 points, or 0.6%, at 18,561.70. The AIM All-Share index was down 2.25 points, or 0.3%, at 873.97.

The Cboe UK 100 index was down 0.5% at 711.88. The Cboe 250 was down 0.7% at 16,204.25, and the Cboe Small Companies was flat at 13,277.87.

In mainland Europe, the CAC 40 stock index in Paris was down 0.1%, while the DAX 40 in Frankfurt was down 0.3%.

"The increasing consensus is that central banks, quite simply, misjudged inflation," said Richard Hunter, head of markets at Interactive Investor. "As such, they find themselves in catch-up mode and, as reiterated in the forum earlier this week, they are committed to control inflation even if the impacts become recessionary."

In the FTSE 100, oil company Harbour Energy was the worst performer, down 3.1%, tracking a plunge in oil prices.

Brent oil was quoted at USD108.85 a barrel Friday morning, down sharply from USD114.74 a barrel at the London equities close Thursday amid recession fears.

Abrdn was down 2.5% after Citigroup downgraded the asset manager to 'sell' from 'neutral'.

BT Group was down 1.3% after staff at the telecommunications company voted to strike, union bosses announced Thursday, joining workers in various UK sectors protesting over pay as decades-high inflation erodes wages.

Dave Ward, general secretary at the Communication Workers Union, said BT now faces its first national strike since the company's privatisation in the 1980s after a ballot in favour of walking out. It comes after strike action in recent days by tens of thousands of rail workers in addition to stoppages held by senior criminal lawyers.

Elsewhere, Oxford Biomedica was up 3.2% after the gene and cell therapy developer signed a new three-year agreement with AstraZeneca, which would facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine.

AstraZeneca was down 0.8%.

The Oxford, England-based company said that the agreement is an extension of the original 18-month supply & development agreement signed back in September 2020 between the two companies.

Under the new agreement, manufacturing of vaccines at Oxford Biomedica's manufacturing facility will be available to AstraZeneca on an as-needed basis beyond 2022.

On Friday, the Japanese Nikkei 225 index closed down 1.7%. In China, the Shanghai Composite lost 0.3%, while the Hang Seng index in Hong Kong was closed for a holiday. The S&P/ASX 200 in Sydney ended down 0.4%.

China's manufacturing sector returned to expansion levels in June, with the easing of Covid restrictions leading to a sharp expansion of output, and the stabilisation of supply chains, data from Caixin and S&P Global showed.

The Caixin general manufacturing purchasing managers' index rose to 51.7 points in June from 48.1 points in May, signalling the first improvement in the sector in four months, as well as the strongest rate of increase since May 2021.

Companies noted the first expansion of output since February, as a result of the return to more normal operations, as well as the reopening of production lines as Covid restrictions were relaxed.

In Japan, the au Jibun manufacturing PMI slowed to 52.7 in June from 53.3 in May, which was the 17th consecutive month of growth.

"The weaker headline reading was partly due to a near-stagnation of new orders. While remaining in expansion territory, the latest increase in sales was only fractional and the slowest in the current nine-month sequence of growth. The slowdown in demand was commonly linked to rising prices and weaker client confidence amid sustained material shortages and delivery delays," au Jibun explained.

The pound was quoted at USD1.2125 early Friday, down from USD1.2157 at the London equities close Thursday.

The euro was priced at USD1.0440, down from USD1.0456. Against the safe haven Japanese yen, the dollar was trading at JPY134.92, lower against JPY135.89.

Gold was quoted at USD1,796.30 an ounce, down from USD1,807.91 late Thursday.

Friday's economic calendar has manufacturing PMIs from the eurozone at 0900 BST and UK at 0930 BST. There is also eurozone inflation at 1000 BST and US PMIs at 1445 BST and 1500 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
29 Apr 2024 16:58

LONDON MARKET CLOSE: FTSE 100 as investors look to Fed rate decision

(Alliance News) - The FTSE 100 in London closed higher on Monday, outperforming its European counterparts, as investors eye this week's interest rate decision from the US Federal Reserve.

Read more
29 Apr 2024 10:42

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumps

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
29 Apr 2024 08:09

Oxford Biomedica confident as it moves away from vaccine era

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.

Read more
22 Apr 2024 14:45

UK earnings, trading statements calendar - next 7 days

Tuesday 23 April 
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Apr 2024 09:43

LONDON BROKER RATINGS: HSBC likes Haleon, cuts Flutter to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Mar 2024 17:09

EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Mar 2024 16:22

Oxford Biomedica shares rise on post-acquisition guidance

(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.

Read more
5 Mar 2024 08:57

LONDON BROKER RATINGS: Barclays cuts Bank of Ireland to 'equal weight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Feb 2024 11:34

EnSilica hires new chief financial officer from Oxford Biomedica

(Alliance News) - EnSilica PLC on Monday said it has appointed a new chief financial officer, who will join the company and board in May.

Read more
29 Jan 2024 12:35

IN BRIEF: Institut Merieux ups stake in Oxford BioMedica toward 10%

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy - Completes purchase of ABL Europe SAS from Institut Merieux SA, cementing the partnership between Oxford BioMedica and Institut Merieux. ABL is a cell and gene therapy contract development and manufacturing organization with facilities in Lyon and Strasbourg in France. For the EUR15 million acquisition, Oxford BioMedica will issue 3.1 million new shares to Lyon-based Institut Merieux at a price of 407.4 pence, well above its current market price. This is a 3.2% stake, and Institut Merieux already had 3.3%, giving it a total 6.5% holding. Oxford BioMedica says Institut Merieux intends to raise this to 10.0% by the end of the September.

Read more
7 Dec 2023 21:10

Oxford BioMedica posts optimistic outlook on uptick in contract value

(Alliance News) - Oxford BioMedica PLC on Thursday said it is on track to achieve its guidance for the year, amid an uptick in current contracted value and growth supported by new orders.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
4 Dec 2023 10:32

Oxford BioMedica buys ABL Europe for consideration of EUR15 million

(Alliance News) - Oxford BioMedica PLC on Monday said that it has entered a sale and purchase agreement with TSGH SAS for the acquisition of ABL Europe SAS.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.